Bluejay Therapeutics logo

Bluejay Therapeutics, Inc.

Biotechnology

Bluejay Therapeutics Stock

Bluejay Therapeutics is a biopharmaceutical company dedicated to developing innovative therapies for liver diseases, with a primary focus on hepatitis B. Founded to address unmet medical needs, the company leverages advanced technologies to create effective and accessible treatments.

For more Bluejay Therapeutics stock information, or to buy or sell private shares, sign up for a MicroVentures account.

Management Team

Keting Chu Founder and Chief Executive Officer
Hassan Javanbakht Chief Scientific Officer
Nancy Shulman Chief Medical Officer

Funding Information